Envoy Medical vs Fractyl Health
COCH and GUTS side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How COCH and GUTS compare
Envoy Medical is the larger company, worth 4.3 times as much as Fractyl Health ($51.5M against $12.0M).
Envoy Medical scores higher on the StockData Score (6 against 1 for Fractyl Health), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | COCH | GUTS |
|---|---|---|
| Size and price | ||
| Market cap | $51.5M | $12.0M |
| Share price | $6.74 | $0.904 |
| Change, 1 year | −7.7% | −93.3% |
| Change, 5 years | −93.1% | – |
| Beta (5Y) | −0.42 | 1.67 |
| Employees | 43 | 100 |
| StockData Score | ||
| Total score | 6 (better) | 1 |
| Valuation score | 0 | 0 |
| Growth score | 1 (better) | 0 |
| Performance score | 0 | 0 |
| Health score | 5 (better) | 1 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 223× | – |
| Growth | ||
| Revenue growth (TTM) | 11.1% | – |
| Profitability | ||
| Gross margin | −353% | – |
| Operating margin | −10343% | – |
| Net margin | −9026% | – |
| Financial health | ||
| Current ratio | 1.21 | 1.98 (better) |
| Altman Z-score | −26.63 | −16.16 (better) |
| Piotroski F-score | 2 | 3 (better) |
| Dividends and buybacks | ||
| Buyback yield | −58.3% | – |
| Shareholder yield | −58.3% | 0.00% (better) |
| Ownership | ||
| Held by institutions | 39.7% | 51.6% |
| Held by insiders | – | 66.1% |
| Insider net buying, 12 months | $8.2M (better) | $187K |
| Short interest, % of float | – | 13.0% |
Go deeper
- COCH stock overview
- COCH income statement
- COCH valuation and score
- GUTS stock overview
- GUTS income statement
- GUTS valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.